News - UF Innovate

FDA Approves Blood Test Developed by Abbott, USAMMDA for Traumatic Brain Injury

The U.S. Food and Drug Administration recently approved a blood test the U.S. Army Medical Materiel Development Activity at Fort Detrick worked on with Abbott Point of Care, which can detect signs of traumatic brain injury more quickly than a previous test by UF startup Banyan Biomarkers. Banyan's biomarkers are used in the new device.

First Cohort Benefits From Atsena Therapeutics XLRS Gene Therapy

UF startup Atsena Therapeutics has announced positive preliminary data for its gene therapy candidate ATSN-201 for the treatment of X-linked retinoschisis (XLRS).

UF-Developed mRNA Vaccine Triggers Fierce Immune Response To Fight Malignant Brain Tumor

In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor.

UF Innovate Startups Transition into 35 Mules Program for Continued Growth

Three companies created by University of Florida students with vastly different ideas find their journeys intertwined through their foundational education at UF, participation in the Big Idea Competition, and subsequent incubation at the 35 Mules Innovation Hub.

Tech Tuesday: BioFlorida

In this week's Tech Tuesday for WCJB TV20, UF Innovate's Bethany Gaffey interviews Mark Glickman, president and CEO of BioFlorida, a statewide organization dedicated to connecting the life sciences across Florida.

AxoGen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™

UF startup and UF Innovate | Accelerate graduate Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical implantations of its newest product, Avive+ Soft Tissue Matrix™.

University of Florida Transportation Institute Revolutionizes Transportation Technology Through Grand Opening of Its $2M I-STREET™ Living Lab

The University of Florida Transportation Institute hosted a grand open unveiling its I-STREET™ Living Lab. I-STREET stands for Implementing Solutions from Transportation Research and Evaluation of Emerging Technologies. As a living lab on the UF campus, it connects surrounding roadway networks on the UF campus, the COG, and across the state using various cutting-edge technologies.

UF Health Researcher on Team Whose Work Could Be Vital in Fighting Drug-Resistant Bacteria

UF researcher Eric Nelson, M.D., Ph.D., and his international team of collaborators published a study in Science on April 18 revealing key insights into how bacteria killers called bacteriophages or phages impact the severity of the waterborne diarrheal disease cholera.

UF Engineering Professor Elected to the American Academy of Arts and Sciences

The American Academy of Arts and Sciences has elected University of Florida computer science professor and National Medal of Technology and Innovation (NMTI) laureate Juan E. Gilbert, Ph.D. as a 2024 Academy member. The Academy, founded in 1780 by John Adams and John Hancock, elects leaders from all disciplines who work together to solve the problems that our nation faces and believes in cultivating a membership of innovators across all fields of arts and sciences.

Cannabix’s Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency

UF startup Cannabix Technologies Inc., developer of alcohol and marijuana breathalyzer screening devices for law enforcement and the workplace reports that Friedel, LLC, a private monitoring agency based in Montana, has deployed the Breath Logix Alcohol Breathalyzer (formerly known as the “CAB” product offering) under its 24/7 Sobriety Program.

UF News